The present invention is directed to compounds of Formula I: ##STR00001## which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.

 
Web www.patentalert.com

< Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

> Tri-substituted ureas as cytokine inhibitors
~ 00473